Author supplied keywords
- ACC/AHA Clinical Practice Guidelines
- Guidelines
- LDL-cholesterol
- biomarkers
- cardiovascular disease
- cholesterol
- coronary artery calcium score
- diabetes mellitus
- drug therapy
- ezetimibe
- hydroxymethylglutaryl-CoA reductase inhibitors/statins
- hypercholesterolemia
- lipids
- patient compliance
- pharmacological
- primary prevention
- proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors
- risk assessment
- risk reduction discussion
- risk treatment discussion
- secondary prevention
Cite
CITATION STYLE
APA
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., … Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 73(24), 3168–3209. https://doi.org/10.1016/j.jacc.2018.11.002
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free